Aberrant EZHIP Expression Drives Tumorigenesis in Osteosarcoma
ChIP-seq / ATAC-seq (genome binding and open chromatin) · human · 51 samples
- What it is
- ChIP-seq / ATAC-seq (genome binding and open chromatin)Where proteins bind the genome, or which regions are open and active.
- Organism
- Homo sapiens (human)
- Topic
- OsteosarcomaThis series is part of our curated briefing on it.
- Samples
- 51 samples: 12 conditions, mostly in triplicateGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- Aberrant EZHIP expression drives tumorigenesis in osteosarcomaNature communications · 2025
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE241106_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: Look for peak files (.bed, .narrowPeak) and signal tracks (.bigWig) among the supplementary files; the raw reads are on ENA.
Also filed as BioProject PRJNA1006401 and SRA study SRP455682. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 35 samples.
How we read this: 12 replicated groups read from 51 sample titles; they account for 35 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM7716747 hMSC cell line EZHIP over expression rep 1 hMSC cell line EZHIP ov…
- GSM7716748 hMSC cell line EZHIP over expression rep 2 hMSC cell line EZHIP ov…
- GSM7716749 hMSC cell line EZHIP over expression rep 3 hMSC cell line EZHIP ov…
- GSM7716750 hMSC cell line WT rep 1 hMSC cell line WT
- GSM7716751 hMSC cell line WT rep 2 hMSC cell line WT
- GSM7716752 hMSC cell line WT rep 3 hMSC cell line WT
- GSM7716753 KHOS cell line EZHIP over expression rep 1 KHOS cell line EZHIP ov…
- GSM7716754 KHOS cell line EZHIP over expression rep 2 KHOS cell line EZHIP ov…
- GSM7716755 KHOS cell line EZHIP over expression rep 3 KHOS cell line EZHIP ov…
- GSM7716756 KHOS cell line WT rep 1 KHOS cell line WT
- GSM7716757 KHOS cell line WT rep 2 KHOS cell line WT
- GSM7716758 KHOS cell line WT rep 3 KHOS cell line WT
- GSM7716759 MG63 cell line EZHIP over expression rep 1 MG63 cell line EZHIP ov…
- GSM7716760 MG63 cell line EZHIP over expression rep 2 MG63 cell line EZHIP ov…
- GSM7716761 MG63 cell line EZHIP over expression rep 3 MG63 cell line EZHIP ov…
- GSM7716762 MG63 cell line WT rep 1 MG63 cell line WT
- GSM7716763 MG63 cell line WT rep 2 MG63 cell line WT
- GSM7716764 MG63 cell line WT rep 3 MG63 cell line WT
- GSM7716765 U2OS cell line parental EZHIP rep 1 U2OS cell line parental…
- GSM7716766 U2OS cell line parental EZHIP rep 2 U2OS cell line parental…
- GSM7716767 U2OS cell line parental EZHIP rep 3 U2OS cell line parental…
- GSM7716768 U2OS cell line EZHIP knock out rep 1 U2OS cell line EZHIP k…
- GSM7716769 U2OS cell line EZHIP knock out rep 2 U2OS cell line EZHIP k…
- GSM7716770 U2OS cell line EZHIP knock out rep 3 U2OS cell line EZHIP k…
- GSM7716771 KHOS Xenograft EZHIP over expression rep 1 KHOS Xenograft EZHIP ov…
- GSM7716772 KHOS Xenograft EZHIP over expression rep 2 KHOS Xenograft EZHIP ov…
- GSM7716773 KHOS Xenograft EZHIP over expression rep 3 KHOS Xenograft EZHIP ov…
- GSM7716774 KHOS Xenograft WT rep 1 KHOS Xenograft WT
- GSM7716775 KHOS Xenograft WT rep 2 KHOS Xenograft WT
- GSM7716776 KHOS Xenograft WT rep 3 KHOS Xenograft WT
- GSM7716777 MG63 Xenograft EZHIP over expression rep 1 MG63 Xenograft EZHIP ov…
- GSM7716778 MG63 Xenograft EZHIP over expression rep 2 MG63 Xenograft EZHIP ov…
- GSM7716779 MG63 Xenograft EZHIP over expression rep 3 MG63 Xenograft EZHIP ov…
- GSM7716780 MG63 Xenograft WT rep 1 MG63 Xenograft WT
- GSM7716781 MG63 Xenograft WT rep 2 MG63 Xenograft WT
- GSM8747683 KHOS cell line EZHIP over expression rep 1 H3K27me3
- GSM8747685 KHOS cell line parental rep 1 H3K27me3
- GSM8747686 KHOS cell line parental rep 2 H3K27me3
- GSM8747687 MG63 cell line EZHIP over expression rep 1 H3K27me3
- GSM8747688 MG63 cell line EZHIP over expression rep 2 H3K27me3
+ 11 more — browse all 51 samples with per-sample file links →
- GSE317900 ZDHHC8-mediated β-catenin palmitoylation promotes WNT signaling activation and drives cisplatin resistance in osteosarcoma 8 samples same disease briefing · shares osteosarcoma, drives
- GSE270231 Aberrant activation of wound healing programs within the metastatic niche facilitates lung colonization by osteosarcoma cells 7 samples same disease briefing · shares osteosarcoma, aberrant
- GSE308128 Tumor Extracellular Vesicles lncOSLMT Drives Lung Inflammatory Premetastatic Niche Formation in Osteosarcoma via m6A-Dependent hnRNPA2B1/COX-2 Axis 6 samples same disease briefing · shares osteosarcoma, drives
- GSE307240 Epigenetic and transcriptional heterogeneity define osteosarcoma subtypes and establish targetable vulnerabilities [multiomics] 10 samples same disease briefing · shares osteosarcoma
- GSE270504 Epigenetic heterogeneity and state-specific transcriptional programs determine differential drug response in osteosarcoma [snRNAseq + snATACseq] 4 samples same disease briefing · shares osteosarcoma
- GSE42352 Genome-wide gene expression profiling of mesenchymal stem cells, osteosarcoma cells, and osteosarcoma cell lines. 118 samples same disease briefing · shares osteosarcoma
- GSE21257 Genome-wide gene expression profiling on pre-chemotherapy biopsies of osteosarcoma patients who developed metastases within 5yrs (n=34) and patients who did not develop metastases within 5yrs (n=19) 53 samples same disease briefing · shares osteosarcoma
- GSE154540 CDK4 overexpression is a predictive biomarker for resistance to conventional chemotherapy in osteosarcoma patients 50 samples same disease briefing · shares osteosarcoma
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.